$INFU new climb
AMEX $3.17
Called 12/01/13
website
$INFU new climb
AMEX $3.17
Called 12/01/13
website
Shares Outstanding: 22.51M
Float: 9.58M
% Held by Insiders: 45.76%
% Held by Institutions: 42.30%
Shares Short (as of Jan 15, 2016): 434.70K
Short Ratio (as of Jan 15, 2016): 31.19
Short % of Float (as of Jan 15, 2016): 2.17%
Shares Short (prior month): 430.75K
Headlines
Company Profile - InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. It delivers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SEC Adjusts Enforcement Focus to Address Cyber Fraud The U.S. Securities and Exchange Commission (SEC) is making significant changes to its enforcement strategy, signaling a shift from its previous stance on cryptocurrency regulation. This restructuring involves scaling back its cryptocurrency oversight unit and creating a specialized team dedicated to tackling cyber...
Continue Reading
Notable Shifts in DuPont Stock Sentiment The whispers in the market are getting harder to ignore—DuPont de Nemours Inc (NYSE:DD) is seeing some serious strife under its surface. Just recently, the short interest on this stock has crept up by a hefty 23.76%. Folks, that’s not just a passing trend; it’s a flashing neon sign that says something's off in the minds of...
Continue Reading
Unlocking Your Potential: The Power of Muscle Building In an age where fitness lies at the forefront of many people's aspirations, finding a solid workout routine tailored for muscle growth has never been more critical. For men looking for rapid muscle development, CrazyBulk muscle gaining supplements are setting a new standard in the fitness community. This approach...
Continue Reading
Goldswarm Honey Takes a Sweet Step for Pollinators A new partnership has blossomed between Goldswarm Honey and a renowned research institution aimed at safeguarding the vital pollinators that are essential to a significant portion of our food supply. This collaboration not only highlights a deep commitment to environmental conservation but also bridges two cultures...
Continue Reading
Idexx Laboratories Faces Revenue Growth Challenges Idexx Laboratories Inc (NASDAQ: IDXX) reported its third-quarter earnings, showcasing an adjusted EPS of $2.79. This reflected a remarkable 12% increase compared to the previous year, surpassing analyst expectations which were set at $2.68. Sales Performance Overview During this quarter, the company achieved sales...
Continue Reading